These grants are designed to provide critical and significant seed funding for experienced investigators with a novel and promising approach to finding causes and cures for childhood cancers. A Letter of Intent is required. The Innovation Award amount totals $250,000 over two years. The Award may not be renewed, however, one no cost extensions are allowable.
- Required Letter of Intent Due: Oct. 16, 2024
- Full Application Due: March 18, 2025
• Applicant institutions must be based in the United States or Canada. Applicants need not be United States citizens. Funds must be granted to nonprofit institutions or organizations.
• Applicants must have an MD, PhD, or MD/PhD (or equivalent) and be appointed as faculty (or equivalent) at an academic institution.
• Applicants must have a track record of publication with at least one publication as a Senior Corresponding Author and funding productivity that demonstrates the project can be accomplished by the investigators.
• Applicants must have a track record of research grant productivity with at least one NIH R01 equivalent awarded.
• Applicant must propose a new research direction, not a continuation of ongoing funded research.
The requested budget should be in proportion to the scope of the proposed project and should be for direct costs of $250,000 USD or below over two years. A maximum of $125,000 in total direct costs may be requested per year.